NSAID	Non-steroidal anti-inflammatory drug
FDA	Food and Drug Administration
CML	Chronic myelogenous leukemia
COX	Cyclooxygenase
EMT	Epithelial–mesenchymal transition
MMP	Matrix metalloproteinase
IC50	Half-maximal inhibitory concentrations
5′-GMP	2′-deoxyguanosine 5′-monophosphate sodium salt hydrate
CDDP	cis-Diaminedichloroplatinum
TNF-α	Tumor necrosis factor-α
NMR	Nuclear magnetic resonance
MTT	3–(4,5–dimethylthiazol–2–yl)–2,5–diphenyltetrazolium bromide
CV	Cyclic voltammetry
RP-HPLC	Reverse phase–high performance liquid chromatography
AR	Accumulation ratio
RT-Qpcr	Quantitative reverse transcription polymerase chain reaction
NHS	N-hydroxysuccinimide
SI	Selectivity index
TBTU	2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate
DMF	N,N-Dimethylformamide
ICP-MS	Inductively coupled plasma mass spectrometry
ESI-MS	Electrospray ionization mass spectrometry
PDK	Pyruvate dehydrogenase kinase
PhB	Phenybutyrate
Val	Valproate
HDAC	Histone deacetylase
PDHC	Pyruvate dehydrogenase complex
HPLC	High performance liquid chromatography
ROS	Reactive oxygen species
DCA	Dichloroacetate
MTA	Microtubule targeting agent